Potential for development of antibiotic resistance in pathogenic treponemes

Clinical Infectious Diseases

Volumn 7, Issue , 1985, Pages S314-S317

  Stapleton, Jack T ^a   Stamm, Lola V ^a   Bassford, Philip J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ARTICLE; DRUG EFFECT; HUMAN; PENICILLIN RESISTANCE; SYPHILIS; TREPONEMA; TREPONEMA PALLIDUM; YAWS;

ANTIBIOTICS; ERYTHROMYCIN; HUMAN; PENICILLIN RESISTANCE; PENICILLINS; SUPPORT, U.S. GOV'T, P.H.S.; SYPHILIS; TREPONEMA; TREPONEMA PALLIDUM; YAWS;

EID: 0022068134     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/7-Supplement_2.S314     Document Type: Article

References (24)

1. Report of a WHO Scientific Group. Treponemal infections.WHO Tech Rep Ser 1982;674:16-52.
2. Norgard MV, Miller JN. Plasmid DNA in Treponema pallidum (Nichols): potential for antibiotic resistance by syphilis bacteria. Science 1981;213:553-5
3. Loughlin EH, Joseph A, Schaeffer K. Aureomycin in the treatment of yaws. Am J Trop Med Hyg 1951;31:20-5
4. Payne EH, Bellerive A, Jean L. Chloromycetin as a treatment for yaws and tropical ulcer. Antibiot Chemother 1951;1:88-91
5. Sell S, Norris SJ. The biology, pathology, and immunology of syphilis. Int Rev Exp Pathol 1983;24:203-76
6. Thornburg RW, Baseman JB. Comparison of major protein antigens and protein profiles of Treponema pallidum and Treponema pertenue. Infect Immun 1983;42:623-7
7. Baker-Zander SA, Lukehart SA. Molecular basis of immunological cross-reactivity between Treponema pallidum and Treponema pertenue. Infect Immun 1983;42: 634-8
8. Stamm LV, Bassford PJ Jr. Cellular and extracellular protein antigens of Treponema pallidum synthesized during in vitro incubation of freshly extracted organisms. Infect Immun 1985;47:799-807
9. Turner TB, Hollander DH. Biology of the treponematoses.Monograph series no. 35. Geneva: World Health Organization, 1957:1-278.
10. Rein MF. Biopharmacology of syphilotherapy. Journal of the American Venereal Disease Association 1976;34: 81-91
11. Panconesi E, Zuccati G, Cantini A. Treatment of syphilis: a short critical review. Sex Transm Dis 1981;8:321-5.
12. Giles AJH, Lawrence AG. Treatment failure with penicillin in early syphilis. Br J Vener Dis 1979;55:62-4.
13. Hardy JB, Hardy PH, Oppenheimer EH, Ryans SJ Jr, Sheff RN. Failure of penicillin in a newborn with congenital syphilis. JAMA 1970;212:1345-9.
14. Idspe O, Guthe T, Willcox RR. Penicillin in the treatment of syphilis. The experience of three decades. Bull WHO 1972;47 (Suppl):1-68
15. Hashisaki P, Wertzberger GG, Conrad GL, Nichols CR. Erythromycin failure in the treatment of syphilis in a pregnant woman. Sex Transm Dis 1983;10:36-85.
16. South MA, Short DH, Knox JM. Failure of erythromycin estolate therapy in in utero syphilis. JAMA 1964;190: 70-1
17. Fenton LJ, Light IJ. Congenital syphilis after maternal treatment with erythromycin. Obstet Gynecol 1976;47: 492-4
18. Duncan WC, Knox JM. Cephalexin therapy for infectious syphilis. Arch Dermatol 1974;110:77-80.
19. Nicolis G, Loucopoulos A. Cephalothin in the treatment of syphilis. Br J Vener Dis 1974;50:270-1.
20. Theodoridis A, Stratigos J, Varelzidis A, Capetanakis J. Cephradine in the treatment of infectious syphilis. Current Therapeutic Research 1976;20:254-6.
21. Johnson RC, Bey RF, Wolgamot SJ. Comparison of the activities of ceftriaxone and penicillin G against experimentally induced syphilis in rabbits. Antimicrob Agents Chemother 1982;21:984-9
22. Foster TJ. Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiol Rev 1983;47:361-409
23. Cohen SN. Transposable genetic elements and plasmid evolution. Nature 1976;263:731-8
24. L Levy SB. Microbial resistance to antibiotics. An evolving and persistent problem. Lancet 1982;2:83-8